|
1
|
Powathil GG, Adamson DJ and Chaplain MA:
Towards predicting the response of a solid tumour to chemotherapy
and radiotherapy treatments: Clinical insights from a computational
model. PLoS Comput Biol. 9:e10031202013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirose A, Sato E, Fujii H, Sun B, Nishioka
H and Aruoma OI: The influence of active hexose correlated compound
(AHCC) on cisplatin-evoked chemotherapeutic and side effects in
tumor-bearing mice. Toxicol Appl Pharmacol. 222:152–158. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dantzer R, Meagher MW and Cleeland CS:
Translational approaches to treatment-induced symptoms in cancer
patients. Nat Rev Clin Oncol. 9:414–426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cleeland CS, Allen JD, Roberts SA, Brell
JM, Giralt SA, Khakoo AY, Kirch RA, Kwitkowski VE, Liao Z and
Skillings J: Reducing the toxicity of cancer therapy: Recognizing
needs, taking action. Nat Rev Clin Oncol. 9:471–478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong J, Su S, Wang M and Zhan Z: Shenqi
fuzheng, an injection concocted from Chinese medicinal herbs,
combined with platinum-based chemotherapy for advanced non-small
cell lung cancer: A systematic review. J Exp Clin Cancer Res.
29:1372010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arcamone F, Penco S and Vigevani A:
Adriamycin (NSC-123127): New chemical developments and analogs.
Cancer Chemother. 6:123–129. 1975.
|
|
7
|
Huang CH and Chiang CP: Bladder
instillation of adriamycin in the treatment of bladder cancer.
Cancer Chemother Pharmacol. 11(Suppl): S91–S93. 1983.PubMed/NCBI
|
|
8
|
Matsumura Y, Tsushima T, Ozaki Y,
Yoshimoto J, Akagi T, Obama T, Nash Y and Ohmori H: Intravesical
chemotherapy with 4′-epi-Adriamycin in patients with superficial
bladder tumors. Cancer Chemother Pharmacol. 16:176–177. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maksimenko A, Dosio F, Mougin J, Ferrero
A, Wack S, Reddy LH, Weyn AA, Lepeltier E, Bourgaux C, Stella B, et
al: A unique squalenoylated and nonpegylated doxorubicin
nanomedicine with systemic long-circulating properties and
anticancer activity. Proc Natl Acad Sci USA. 111:E217–E226. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nair KL, Jagadeeshan S, Nair SA and Kumar
GS: Biological evaluation of 5-fluorouracil nanoparticles for
cancer chemotherapy and its dependence on the carrier, PLGA. Int J
Nanomedicine. 6:1685–1697. 2011.PubMed/NCBI
|
|
12
|
Mitchell MS and Deconti RC:
Immunosuppression by 5-fluorouracil. Cancer. 26:884–889. 1970.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Upur H, Yusup A, Umar A and Moore N:
Uighur traditional medicine syndrome of Abnormal Savda in men is
associated with oxidative stress, which can be improved by Munziq
and Mushil of Abnormal Savda. Therapie. 59:483–484. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yusup A, Upur H, Umar A, Berke B, Yimit D,
Lapham JC, Moore N and Cassand P: Abnormal Savda Munziq, an Herbal
Preparation of Traditional Uighur Medicine, May Prevent
1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis. Evid Based
Complement Alternat Med. 2011:1520152011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yusup A, Upur H, Baudrimont I, Umar A,
Kader T, Begaud B, Creppy EE and Moore N: Cytotoxicity of abnormal
Savda Munziq aqueous extract in human hepatoma (HepG2) cells.
Fundam Clin Pharmacol. 19:465–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abliz G, Mijit F, Hua L, Abdixkur G,
Ablimit T, Amat N and Upur H: Anti-carcinogenic effects of the
phenolic-rich extract from abnormal Savda Munziq in association
with its cytotoxicity, apoptosis-inducing properties and telomerase
activity in human cervical cancer cells (SiHa). BMC Complement
Altern Med. 15:232015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yusup A, Upur H, Umar A and Moore N:
Protective effects of Munziq and Mushil of abnormal Savda to
mitochondrial oxidative damage. Fundam Clin Pharmacol. 18:471–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parekh H, Advani S and Chitnis M: Bepridil
enhances adriamycin-induced DNA biosynthesis inhibition in human
myeloid leukemia cells. Sel Cancer Ther. 6:183–191. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gupta V, Lahiri S, Sultana S, Tulsawani R
and Kumar R: Anti-oxidative effect of Rhodiola imbricata root
extract in rats during cold, hypoxia and restraint (C-H-R) exposure
and post-stress recovery. Food Chem Toxicol. 48:1019–1025. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ku SK, Seo BI, Park JH, Park GY, Seo YB,
Kim JS, Lee HS and Roh SS: Effect of Lonicerae Flos extracts on
reflux esophagitis with antioxidant activity. World J
Gastroenterol. 15:4799–4805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salo DC, Lin SW, Pacifici RE and Davies
KJ: Superoxide dismutase is preferentially degraded by a
proteolytic system from red blood cells following oxidative
modification by hydrogen peroxide. Free Radic Biol Med. 5:335–339.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Upur H, Yusup A, Baudrimont I, Umar A,
Berke B, Yimit D, Lapham JC, Creppy EE and Moore N: Inhibition of
cell growth and cellular protein, DNA and RNA synthesis in human
hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq
of traditional Uighur medicine. Evid Based Complement Alternat Med.
2011:2514242011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yusup A, Upur H, Tursun X, Berke B,
Baudrimont I and Moore N: Study on mechanism of abnormal savda
munziq flavonoids in induction of apoptosis of Hep2 cells. Zhongguo
Zhong Yao Za Zhi. 32:1068–1071. 2007.(In Chinese). PubMed/NCBI
|
|
24
|
Yusup A, Upur H, Umar A, Berke B and Moore
N: Ethanol extract of abnormal Savda Munziq, a herbal preparation
of traditional Uighur medicine, inhibits Caco-2 cells proliferation
via cell cycle arrest and apoptosis. Evid Based Complement Alternat
Med. 2012:9263292012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yusup A, Upur H, Umar A, Berke B, Yimit D,
Lapham JC, Moore N and Cassand P: Abnormal Savda Munziq, an herbal
preparation of traditional Uighur medicine, may prevent
1,2-dimethylhydrazine-induced rat colon carcinogenesis. Evid Based
Complement Alternat Med. 2011:1520152011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sim AS, Salonikas C, Naidoo D and Wilcken
DE: Improved method for plasma malondialdehyde measurement by high
performance liquid chromatography using methyl malondialdehyde as
an internal standard. J Chromatogr B Analyt Technol Biomed Life
Sci. 758:337–344. 2003. View Article : Google Scholar
|
|
27
|
Gerber DE and Schiller JH: Maintenance
chemotherapy for advanced non-small-cell lung cancer: New life for
an old idea. J Clin Oncol. 31:1009–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hedigan K: Cancer: Herbal medicine reduces
chemotherapy toxicity. Nat Rev Drug Discov. 9:7652010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lam W, Bussom S, Guan F, Jiang Z, Zhang W,
Gullen EA, Liu SH and Cheng YC: The four-herb Chinese medicine
PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci
Transl Med. 2:45ra592010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Joensuu H, Holli K, Heikkinen M, Suonio E,
Aro AR, Hietanen P and Huovinen R: Combination chemotherapy versus
single-agent therapy as first- and second-line treatment in
metastatic breast cancer: A prospective randomized trial. J Clin
Oncol. 16:3720–3730. 1998.PubMed/NCBI
|
|
31
|
Floyd J, Mirza I, Sachs B and Perry MC:
Hepatotoxicity of chemotherapy. Semin Oncol. 33:50–67. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jassem J, Pieńkowski T, Płuzańska A, Jelic
S, Gorbunova V, Mrsic-Krmpotic Z, Berzins J, Nagykalnai T, Wigler
N, Renard J, et al: Doxorubicin and paclitaxel versus fluorouracil,
doxorubicin, and cyclophosphamide as first-line therapy for women
with metastatic breast cancer: Final results of a randomized phase
III multicenter trial. J Clin Oncol. 19:1707–1715. 2001.PubMed/NCBI
|
|
33
|
Ciccolini J, Mercier C, Blachon MF, Favre
R, Durand A and Lacarelle B: A simple and rapid high-performance
liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU)
assay in plasma and possible detection of patients with impaired
dihydropyrimidine dehydrogenase (DPD) activity. J Clin Pharm Ther.
29:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Compagnon P, Thiberville L, Moore N,
Thuillez C and Lacroix C: Simple high-performance liquid
chromatographic method for the quantitation of 5-fluorouracil in
human plasma. J Chromatogr B Biomed Appl. 677:380–383. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou Q and Chowbay B: Determination of
doxorubicin and its metabolites in rat serum and bile by LC:
Application to preclinical pharmacokinetic studies. J Pharm Biomed
Anal. 30:1063–1074. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishak KG and Zimmerman HJ: Morphologic
spectrum of drug-induced hepatic disease. Gastroenterol Clin North
Am. 24:759–786. 1995.PubMed/NCBI
|
|
37
|
Ray S, Roy K and Sengupta C: In vitro
evaluation of protective effects of ascorbic acid and water extract
of Spirulina plantesis (blue green algae) on 5-fluorouracil-induced
lipid peroxidation. Acta Pol Pharm. 64:335–344. 2007.PubMed/NCBI
|
|
38
|
Meredith MJ and Reed DJ: Depletion in
vitro of mitochondrial glutathione in rat hepatocytes and
enhancement of lipid peroxidation by adriamycin and
1,3-bib(2-chloroethyl)1-nitrosurea (BCNU). Biochem Pharmacol.
32:1383–1388. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Farrell GC: Drug-Induced liver disease.
Edinburgh: Churchill Livingstone. 389–412. 1994.
|
|
40
|
Mikalauskas S, Mikalauskiene L, Bruns H,
Nickkholgh A, Hoffmann K, Longerich T, Strupas K, Büchler MW and
Schemmer P: Dietary glycine protects from chemotherapy induced
hepatotoxicity. Amino Acids. 40:1139–1150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sréter I, Kiss A, Cornides A, Vereckei A,
Toncsev H and Fehér J: Inhibition of doxorubicin-induced liver
toxicity by a new dihydroquinoline type antioxidant. Acta Physiol
Hung. 64:431–435. 1984.PubMed/NCBI
|
|
42
|
Singal PK and Iliskovic N:
Doxorubicin-induced cardiomyopathy. N Engl J Med. 339:900–905.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Giri SN, Al-Bayati MA, Du X, Schelegle E,
Mohr FC and Margolin SB: Amelioration of doxorubicin-induced
cardiac and renal toxicity by pirfenidone in rats. Cancer Chemother
Pharmacol. 53:141–150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mordente A, Meucci E, Martorana GE,
Giardina B and Minotti G: Human heart cytosolic reductases and
anthracycline cardiotoxicity. IUBMB Life. 52:83–88. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Doroshow JH, Locker GY and Myers CE:
Enzymatic defenses of the mouse heart against reactive oxygen
metabolites: Alterations produced by doxorubicin. J Clin Invest.
65:128–135. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Keizer HG, Pinedo HM, Schuurhuis GJ and
Joenje H: Doxorubicin (adriamycin): A critical review of free
radical-dependent mechanisms of cytotoxicity. Pharmacol Ther.
47:219–231. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Myers C: The role of iron in
doxorubicin-induced cardiomyopathy. Semin Oncol. 25(4 Suppl 10):
10–40. 1998.PubMed/NCBI
|
|
48
|
Polk A, Vistisen K, Vaage-Nilsen M and
Nielsen DL: A systematic review of the pathophysiology of
5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol.
15:472014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ensley JF, Patel B, Kloner R, Kish JA,
Wynne J and al-Sarraf M: The clinical syndrome of 5-fluorouracil
cardiotoxicity. Invest New Drugs. 7:101–109. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu LL, Li QX, Xia L, Li J and Shao L:
Differential effects of dihydropyridine calcium antagonists on
doxorubicin-induced nephrotoxicity in rats. Toxicology. 231:81–90.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yagmurca M, Erdogan H, Iraz M, Songur A,
Ucar M and Fadillioglu E: Caffeic acid phenethyl ester as a
protective agent against doxorubicin nephrotoxicity in rats. Clin
Chim Acta. 348:27–34. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yilmaz S, Atessahin A, Sahna E, Karahan I
and Ozer S: Protective effect of lycopene on adriamycin-induced
cardiotoxicity and nephrotoxicity. Toxicology. 218:164–171. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yin H, Xu L and Porter NA: Free radical
lipid peroxidation: Mechanisms and analysis. Chem Rev.
111:5944–5972. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu Y, Zhang L and Liang J: Activation of
the Nrf2 defense pathway contributes to neuroprotective effects of
phloretin on oxidative stress injury after cerebral
ischemia/reperfusion in rats. J Neurol Sci. 351:88–92. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
El-Sayyad HI, Ismail MF, Shalaby FM,
Abou-El-Magd RF, Gaur RL, Fernando A, Raj MHG and Ouhtit A:
Histopathological effects of cisplatin, doxorubicin and
5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol
Sci. 5:466–473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Andersen HR, Nielsen JB, Nielsen F and
Grandjean P: Antioxidative enzyme activities in human erythrocytes.
Clin Chem. 43:562–568. 1997.PubMed/NCBI
|
|
57
|
Inal ME, Kanbak G and Sunal E: Antioxidant
enzyme activities and malondialdehyde levels related to aging. Clin
Chim Acta. 305:75–80. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gupta V, Lahiri SS, Sultana S, Tulsawani R
and Kumar R: Anti-oxidative effect of Rhodiola imbricata root
extract in rats during cold, hypoxia and restraint (C-H-R) exposure
and post-stress recovery. Food Chem Toxicol. 48:1019–1025. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Andersen HR, Nielsen JB, Nielsen F and
Grandjean P: Antioxidative enzyme activities in human erythrocytes.
Clinical Chem. 43:562–568. 1997.
|
|
60
|
Inal ME, Kanbak G and Sunal E: Antioxidant
enzyme activities and malondialdehyde levels related to aging. Clin
Chim Acta. 305:75–80. 2001. View Article : Google Scholar : PubMed/NCBI
|
